You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CYP2C19 loss-of-function allele(s) carrier

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stroke, Transient Ischemic Attack Trial in China (Ticagrelor and Aspirin, Clopidogrel and Aspirin)

Recruiting
  • Acute Nondisabling Ischemic Stroke
  • Transient Ischemic Attack
  • Tagrelor combined with aspirin
  • Clopidogrel combined with aspirin
  • Beijing, China
    Peking University Third Hospital
Jun 27, 2021

Coronary Artery Disease Trial in Jacksonville (Prasugrel, Ticagrelor)

Completed
Has Results
  • Coronary Artery Disease
  • Jacksonville, Florida
    University of Florida
Aug 27, 2020

Coronary Artery Disease Trial in Jacksonville (Prasugrel, Ticagrelor)

Completed
Has Results
  • Coronary Artery Disease
  • Jacksonville, Florida
    University of Florida
Aug 27, 2020

Prostate Cancer Patients Trial in Guangzhou (Midazolam, Warfarin, Omeprazole, VitaminK1 and SHR3680)

Unknown status
  • Prostate Cancer Patients
  • Midazolam, Warfarin, Omeprazole, VitaminK1 and SHR3680
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
Dec 15, 2020

Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Gainesville (DNA sample collection)

Recruiting
  • Coronary Artery Disease
  • Percutaneous Coronary Intervention
  • DNA sample collection
  • Gainesville, Florida
    University of Florida
Nov 16, 2023

Coronary Artery Disease, Platelet Reactivity Trial (CYP2C19 genotype guided P2Y12 monotherapy, Clopidogrel)

Not yet recruiting
  • Coronary Artery Disease
  • Platelet Reactivity
  • (no location specified)
Mar 7, 2023

Peripheral Arterial Disease Trial in Netherlands (Direct CYP2C19 genotyping, CYP2C19 genotyping at the end of the study, Poor

Recruiting
  • Peripheral Arterial Disease
  • Direct CYP2C19 genotyping
  • +4 more
  • Apeldoorn, Netherlands
  • +10 more
Apr 19, 2022

Angina, Stable, Acute Coronary Syndrome, Drug-Eluting Stents Trial in Beijing, Xuzhou, Chengdu (CYP2C19 genotype testing)

Recruiting
  • Angina, Stable
  • +3 more
  • CYP2C19 genotype testing
  • Beijing, Beijing, China
  • +11 more
Nov 4, 2021

Ischemic Stroke, Transient Ischemic Attack Trial in Singapore (Genetic testing)

Not yet recruiting
  • Ischemic Stroke
  • Transient Ischemic Attack
  • Genetic testing
  • Singapore, Singapore
    Singapore General Hospital
Mar 9, 2023

Rheumatoid Arthritis Trial in Sofia, Chisinau (Olokizumab, Omeprazole, Caffeine)

Completed
  • Rheumatoid Arthritis
  • Sofia, Bulgaria
  • +1 more
Nov 17, 2022

Rheumatoid Arthritis Trial in Wuhan (SHR0302 Tablets, Midazolam Maleate Tablets, Warfarin Sodium Tablets)

Completed
  • Rheumatoid Arthritis
  • SHR0302 Tablets
  • +5 more
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Dec 21, 2022

Healthy Trial (Voriconazole 200mg, FluvoxaMINE 50 Mg Oral Tablet, Omeprazole 10 MG Oral Tablet)

Not yet recruiting
  • Healthy
  • Voriconazole 200mg
  • +2 more
  • (no location specified)
Feb 21, 2022

Stroke, Transient Ischemic Attack Trial in China (Ticagrelor and Aspirin, Clopidogrel and Aspirin)

Completed
  • Stroke
  • Transient Ischemic Attack
  • Ticagrelor and Aspirin
  • Clopidogrel and Aspirin
  • Anqing, Anhui, China
  • +213 more
Nov 30, 2021

Coronary Artery Disease, Acute Coronary Syndrome, Stenosis Trial in Worldwide (Clopidogrel, Ticagrelor)

Completed
Has Results
  • Coronary Artery Disease
  • +2 more
  • Scottsdale, Arizona
  • +40 more
Oct 11, 2021

NAFLD Trial in Tucson (NAFLD-specific weight loss intervention, Wait-list control)

Not yet recruiting
  • NAFLD
  • NAFLD-specific weight loss intervention
  • Wait-list control
  • Tucson, Arizona
    University of Arizona Collaboratory for Metabolic Disease Preven
Oct 7, 2022

Based on CYP2C19 Genotype in Ischemic Stroke

Active, not recruiting
  • Acute Ischemic Stroke
  • General principles of care and judgement of researcher
  • Yongin-si, Gyeonggi-do, Korea, Republic of
  • +36 more
Oct 23, 2022

Atrial Fibrillation, Coronary Artery Disease Trial (Rivaroxaban)

Not yet recruiting
  • Atrial Fibrillation
  • Coronary Artery Disease
  • (no location specified)
Oct 22, 2023

Genetic Analyses of Nonsyndromic and Syndromic Deafness in

Enrolling by invitation
  • Hearing Disorder
    • Lahore, Pakistan
      University of Punjab
    Jan 25, 2023

    Liver Cirrhosis Trial (Caffeine, Warfarin sodium, Omeprazole)

    Not yet recruiting
    • Liver Cirrhosis
    • (no location specified)
    Feb 14, 2023

    Bleeding Complications Trial in Rochester (Clopidogrel, Prasugrel, Tricagrelor)

    Active, not recruiting
    • Bleeding Complications
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Dec 31, 2022

    Kidney Rejection Transplant Trial in Poznan (Assessment of the drug concentration in the blood)

    Active, not recruiting
    • Kidney Rejection Transplant
    • Assessment of the drug concentration in the blood
    • Poznan, Poland
      University Clinical Hospital in Poznan of the Poznan University
    Jan 19, 2023

    Systemic Lupus Erythematosus and Rheumatoid Arthritis

    Recruiting
    • Systemic Lupus Erythematosus
    • +2 more
    • Belimumab in SLE patients / Rituximab in RA patients
    • Monserrato, Cagliari, Italy
      Matteo Piga
    Dec 13, 2022

    Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR

    Not yet recruiting
    • Amyloidosis, Hereditary
    • +4 more
      • New York, New York
      • +2 more
      Aug 3, 2022

      Natural History Study - Mitochondrial Disease

      Recruiting
      • MELAS or m.3243 A>G Mitochondrial DNA Mutation Carrier
        • New York, New York
          Columbia University
        Jul 28, 2022

        Chronic Hepatitis B Trial (HRS5091 Tablets, Midazolam Maleate Tablets, Warfarin Sodium Tablets)

        Completed
        • Chronic Hepatitis B
        • HRS5091 Tablets
        • +6 more
        • Guangzhou, Guangdong, China
          The Second Affiliated Hospital of Guangzhou Medical University
        Dec 22, 2022